Defining the cellular determinants that drive dynamin inhibitor induced cell death and in vivo efficacy against glioblastoma

Lead Researcher: Dr Megan Chircop

Institution: Children's Medical Research Insitute

Funding: $360,000

Funding Duration: 2014 - 2016

‍

The Research

This project will investigate if dynamin II inhibitors are valid agents for treatment of brain cancers. This research will identify key dynamin inhibitory compounds with anti-cancer properties, ultimately to be used as a chemotherapy agent.